openPR Logo
Press release

Prostatic Arterial Embolization Market To Grow On The Back Of Advances In Urology-Related Medical Procedures During 2019-2027

11-13-2019 12:48 PM CET | Health & Medicine

Press release from: Research Nester Pvt Ltd

Prostatic Arterial Embolization Market To Grow On The Back

Research Nester released a report titled “Prostatic Arterial Embolization Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global prostatic arterial embolization market in terms of market segmentation by product, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Prostatic arterial embolization market is anticipated to grow by a substantial CAGR during the forecast period, i.e., 2019-2027. The market is segmented on the basis of end user into hospitals, ambulatory surgical centers and clinics, out of which, the hospitals segment is estimated to grow at the highest rate during the forecast period. This can be attributed to the growing number of patients with prostate hyperplasia and the rising demand for treatments in hospitals.
According to W.H.O, incidence of prostate hyperplasia among the population of high income countries was found to increase by 15.94% from 2000 to 2012, with 255.3 cases per 100,000 men in 2012. The significant increase in this disorder is anticipated to raise the demand for effective treatment procedures such as prostatic arterial embolization in upcoming years.

Request Free Sample on Prostatic Arterial Embolization Market Report @ https://www.researchnester.com/sample-request-1825

Regionally, the market in Asia Pacific region is anticipated to grow at the notable rate during the forecast period on account of increasing government initiatives and research activities in the region. In addition to this, the growing technological advances in medical industry is another factor estimated to drive the growth of market in this region during the forecast period. Prostatic arterial embolization market in North America is anticipated to hold the largest share in market as a result of rising expenditure by the population on medical treatments along with the presence of highly developed healthcare infrastructure in the region.
Increasing Awareness About Urinary Disorders And Improved Treatment Procedures To Hone The Market Growth

The growing awareness among men about various health issues including urinary tract disorders is estimated to increase the demand for improved medical treatments which are minimally invasive and highly effective. This is a major factor contributing to the growth of prostatic arterial embolization market during the forecast period.
However, the side effects of the procedure, known as the ‘post PAE syndrome’ is estimated to hinder the market growth on account of various symptoms such as nausea, pain, fever and frequent urination which may be present for several days after the treatment.

Request a sample Report of Prostatic Arterial Embolization Market at: https://www.researchnester.com/sample-request-1825

This report also provides the existing competitive scenario of some of the key players of the global prostatic arterial embolization market which includes company profiling of Merit Medical Systems (MMSI), Boston Scientific (BSX), Mentice (MN2), Siemens Healthineers (SHL), Terumo Europe NV and General Electric Company (GE). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global prostatic arterial embolization market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get more information on this report: https://www.researchnester.com/reports/prostatic-arterial-embolization-market/1825

Contact for more Info:
AJ Daniel
Email: sales@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostatic Arterial Embolization Market To Grow On The Back Of Advances In Urology-Related Medical Procedures During 2019-2027 here

News-ID: 1866628 • Views:

More Releases from Research Nester Pvt Ltd

Lutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicators
Lutein and Zeaxanthin Market - Key Players, Capability Assessment & M&A Indicato …
The lutein and zeaxanthin market has expanded steadily as demand for eye-health supplements, functional foods, and preventive nutrition increases across global consumer segments. Lutein and zeaxanthin, two essential carotenoids concentrated in the retina, are widely recognized for their protective roles against oxidative stress, age-related macular degeneration (AMD), blue-light exposure, and general visual fatigue. Their adoption has accelerated with the rise of digital lifestyles, an aging population, and growing clinical evidence
Top Companies in Atrial Fibrillation Market - Benchmarking Performance & Future Value Creation
Top Companies in Atrial Fibrillation Market - Benchmarking Performance & Future …
The atrial fibrillation market is undergoing a period of rapid transformation as diagnostic technologies, catheter-based therapies, and antiarrhythmic solutions continue to advance. Atrial fibrillation (AFib) is one of the most prevalent cardiac arrhythmias globally, prompting significant demand for improved detection, early intervention, and minimally invasive treatment. The shift toward advanced ablation systems, AI-enabled diagnostics, wearable monitoring, and next-generation electro-mapping tools has strengthened competition across the market. Companies are expanding their
Conductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends
Conductive Textiles Market - Top Companies, SWOT Deep Dive & Capital Flow Trends
The conductive textiles market is undergoing a rapid transformation as wearable electronics, smart apparel, and advanced sensor-integrated fabrics move from niche applications to mainstream adoption. Conductive textiles-engineered using conductive polymers, metal-coated fibers, or intrinsically conductive yarns-have become integral to next-generation healthcare wearables, military gear, automotive interiors, and consumer smart devices. As industries push for lighter, flexible, and more energy-efficient electronic systems, conductive materials embedded within fabrics are emerging as a
Global Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Investment Insights
Global Osteosynthesis Devices Market: Top Companies, Market Share Rankings & Inv …
The osteosynthesis devices market continues to evolve as orthopedic care moves toward minimally invasive procedures, biologically compatible materials, and technology-enabled implants. These devices-ranging from plates and screws to intramedullary nails and fixation systems-are essential for treating fractures, deformities, and complex bone injuries. Companies operating in this space are adopting strategies centered around product innovation, clinical efficacy, and expansion into fast-growing regions. As trauma care volumes rise in both developed and

All 5 Releases


More Releases for Prostatic

Rising Geriatric Population Drives Growth Of Benign Prostatic Hypertrophy Drugs …
The Drugs For Benign Prostatic hypertrophy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Drugs For Benign Prostatic hypertrophy Market? The drugs for benign prostatic hypertrophy market has shown strong growth, expanding from $4.28 billion in 2024 to $4.58
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Prominent Drugs For Benign Prostatic hypertrophy Market Trend for 2025: Innovati …
What Are the Projected Growth and Market Size Trends for the Drugs For Benign Prostatic hypertrophy Market? The market size for benign prostatic hypertrophy medication has seen considerable growth in recent years. It is projected to increase from $4.28 billion in 2024 to $4.58 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The significant growth during the historic period can be linked to an aging population, heightened
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.